Skip to main content

NIPT Market Expected to Reach $10.82 Billion By 2030

 

Technological advancements in the healthcare industry have always played a crucial role in its overall development. The recent advancements in the life science industry, such as wearable healthcare devices, sequencing technologies, regenerative medicine, and genomic technologies, supported by breakthroughs in the field of genome sequencing, and molecular research, have opened up new and promising pathways to combat genetic diseases and reduce the overall global economic burden. Several conglomerate companies and start-ups, including Illumina, Inc., F. Hoffmann-La Roche AG, and Diagnomics Inc. based in the developed countries, such as the U.S., the U.K., Germany, China, France, and Canada have been making significant investments in the fields of life sciences to develop promising gene sequencing-based non-invasive diagnostic procedures to promote global health. Among the innumerable advancements witnessed by the industry, non-invasive prenatal testing (NIPT) today stands as one of the most distinctive technologies in curbing the concerns related to genetic diseases.

Prenatal testing is undertaken before the birth of the child to identify chromosomal abnormalities in the fetus, which are at high risk of developing such abnormalities. Prenatal testing comes under the purview of antenatal care”. It involves various techniques and methods which can detect numerous genetic disorders present in the fetus and health problems in pregnant women. These genetic disorders, many of which are inherited, are dominant X-linked autosomal recessive disorders, which are easy to be detected in both conditions: prior to pregnancy and during pregnancy. It has been estimated that at the maternal age of 30 years, the risk of chromosomal abnormality increases approximately to 1/385 live birth rate.

As per BIS Research analysis, the global NIPT market was valued $2.18 billion in 2019, and is expected to reach $10.82 billion by 2030. The growth is attributed to the increasing reimbursement policies and insurance coverage across the globe. Further, the continued significant investments for genome sequencing by healthcare companies to meet the industry demand and growing incidence of genetic disorders are the prominent factors propelling the growth of the global NIPT market. 


Comments

Post a Comment

Popular posts from this blog

Personal Care Ingredients Market Size, Share & Trends Analysis Report 2019-2029

The introduction and proliferation of bio-based ingredients in several industries, such as food and beverage, pharmaceuticals, and cosmetics, has been transforming the manufacturing landscape since 2000. Growing consumer inclination toward the adoption of bio-based products due to rising health and environmental concerns is driving the demand for bio-based ingredients in the cosmetics and personal care products. Besides, awareness among consumers regarding the harmful effects of synthetic ingredients chemicals has grown rapidly over the past years. In addition, the availability of green raw materials has also urged large cosmetic firms to develop bio-based cosmetic products. However, limited availability of raw material, due to erratic weather conditions and stringent environmental regulations, can pose substantial hurdles in the production of bio-based ingredients. Thus, leading companies have been focusing on developing new and sustainable ways of producing the ingredi...
Post a Comment
Read more

Strategies Incorporated to Sustain the Competition

  The strategies followed by various prominent companies to sustain the competition and expand their market share has been varying from mergers and acquisitions (M&A) to collaborations and partnerships. In the past three years (January 2017-September 2020), the market witnessed approximately eight M&A activities, seven partnerships, and alliances (collaborations, joint ventures, and other agreements), one business expansion, and four other developments. Among the different key developments, M&A activities constitute the dominant contributor’s strategies, followed by partnership and alliances. The global bioengineered skin substitutes market is dominated by juggernauts including AbbVie, Inc., Integra LifeSciences Corporation, Smith & Nephew plc, and Stryker Corporation, and other medium and small-medium enterprises that are offering wide ranges of bioengineered skin substitute products in the market. Several companies are attempting to enter the market and sustain...
Post a Comment
Read more

Increasing Adoption of Lidar in Construction Applications

  The construction industry is continuously growing and has been witnessing various technological innovations. The construction industry depicts high complexity, steep costs, and low toleration for error, that facilitate the adoption of laser scanning. Lidars have enabled the construction industry to gain 3D models of existing space and build digital plans on those real spaces. Digital collaboration frameworks such as building information modelling (BIM) deliver the value of the scans to every element of a construction team in formats that are best suited to their needs. BIM schematics also provide continuing value to facility maintenance and operation teams. BIS Research Report on Lidar Market Numerous stages of construction projects are scanned for quality assurance, cross-checking with models, and spotting errors. Lidars can also be deployed for quality evaluation of prefabricated materials, allowing an efficient, and cheap evaluation. Furthermore, lidars find applications i...
Post a Comment
Read more